Your browser doesn't support javascript.
loading
TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling.
Ye, Jianfeng; Liu, Wangmin; Yu, Xueyang; Wu, Lina; Chen, Zhengjie; Yu, Yufei; Wang, Jianfeng; Bai, Song; Zhang, Mo.
Afiliação
  • Ye J; Department of Urology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Liu W; Department of Urology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Yu X; Department of Urology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Wu L; Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Chen Z; Department of Urology, the First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Yu Y; Department of Urology, the First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Wang J; Department of Urology, the First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Bai S; Department of Urology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. baisongcmu@163.com.
  • Zhang M; Department of Urology, the First Hospital of China Medical University, Shenyang, Liaoning, China. peterzhang623@gmail.com.
Cell Death Discov ; 9(1): 378, 2023 Oct 16.
Article em En | MEDLINE | ID: mdl-37845209
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China